NO20035647L - Ny anvendelse av cyclolignaner og nye cycloliganer - Google Patents
Ny anvendelse av cyclolignaner og nye cycloliganerInfo
- Publication number
- NO20035647L NO20035647L NO20035647A NO20035647A NO20035647L NO 20035647 L NO20035647 L NO 20035647L NO 20035647 A NO20035647 A NO 20035647A NO 20035647 A NO20035647 A NO 20035647A NO 20035647 L NO20035647 L NO 20035647L
- Authority
- NO
- Norway
- Prior art keywords
- new
- cycloligans
- cyclolignans
- new use
- new cycloligans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102168A SE0102168D0 (sv) | 2001-06-19 | 2001-06-19 | New use and new compounds |
US30043101P | 2001-06-26 | 2001-06-26 | |
PCT/SE2002/001223 WO2002102805A1 (en) | 2001-06-19 | 2002-06-19 | NEW USE Of CYCLOLIGNANS AND NEW CYCLOLIGNANS |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20035647D0 NO20035647D0 (no) | 2003-12-17 |
NO20035647L true NO20035647L (no) | 2004-02-18 |
Family
ID=26655492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20035647A NO20035647L (no) | 2001-06-19 | 2003-12-17 | Ny anvendelse av cyclolignaner og nye cycloliganer |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2009242406A (ja) |
KR (1) | KR20040030686A (ja) |
AU (2) | AU2009201542B2 (ja) |
DE (1) | DE60233601D1 (ja) |
NO (1) | NO20035647L (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100971364B1 (ko) * | 2009-12-28 | 2010-07-20 | 명 하 윤 | 굴삭기 그라브 실린더의 유압 분배용 어댑터 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0720966B2 (ja) * | 1984-12-28 | 1995-03-08 | コンプハルム・エイビ− | 製薬学的に活性な化合物を含有する病気治療剤 |
JPH09194368A (ja) * | 1996-01-11 | 1997-07-29 | Pola Chem Ind Inc | ポドフィロトキシン誘導体及びそれからなる新規細胞分化誘導剤 |
-
2002
- 2002-06-19 DE DE60233601T patent/DE60233601D1/de not_active Expired - Lifetime
- 2002-06-19 KR KR10-2003-7016623A patent/KR20040030686A/ko not_active Application Discontinuation
-
2003
- 2003-12-17 NO NO20035647A patent/NO20035647L/no unknown
-
2009
- 2009-04-20 AU AU2009201542A patent/AU2009201542B2/en not_active Expired - Fee Related
- 2009-06-03 JP JP2009134006A patent/JP2009242406A/ja active Pending
-
2010
- 2010-02-10 AU AU2010200488A patent/AU2010200488A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20035647D0 (no) | 2003-12-17 |
KR20040030686A (ko) | 2004-04-09 |
AU2009201542A1 (en) | 2009-05-14 |
JP2009242406A (ja) | 2009-10-22 |
AU2009201542B2 (en) | 2011-06-23 |
DE60233601D1 (de) | 2009-10-15 |
AU2010200488A1 (en) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20041272L (no) | Tetracycline derivatives and methods of use thereof | |
NO20034187L (no) | Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer | |
NO20033261D0 (no) | Nye blandinger av mikrobielle enzymer | |
NO20022289D0 (no) | Ny anvendelse og nye N-azabisykloamidderivater | |
DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
NO20014495L (no) | Ny anordning for oksygenering av sjövann | |
ATE370938T1 (de) | Pro-pharmakon von cox-2-inhibitoren | |
NO20040072L (no) | Nye substituerte benzimidazol-doseringsformer og fremgangsmate for anvendelse av samme | |
DK1429769T3 (da) | Nye formuleringer og anvendelse deraf | |
NO20014950D0 (no) | Nye behandlingsmetoder | |
NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
NO20024838L (no) | Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo- 5-aminer | |
IS2867B (is) | Neublastín sem tengt er fjölliðu og aðferðir við notkun þess | |
ATE499096T1 (de) | Kombination von serotonin-wiederaufnahme-hemmern und agomelatin | |
NO20041968L (no) | Anvendelse av cystationin | |
NO20035332D0 (no) | Nye heterocykliske derivater og medisinsk anvendelse derav | |
NO20032440L (no) | Fremgangsmåte for fremstillingen av iopamidol og de nye intermediater deri | |
NO20031928L (no) | Nye krystall- og solvatformer av ondansetron-hydroklorid og fremgangmsmåterfor fremstilling derav | |
NO20030822D0 (no) | Nye forbindelser og fremgangsmåter | |
NO20035331D0 (no) | Nye heterocyklisk forbindelse og medisinsk anvendelse derav | |
IS2331B (is) | 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra | |
NO20025509L (no) | Ny polymorf av torasemid | |
NO20035647D0 (no) | Ny anvendelse av cyclolignaner og nye cycloliganer | |
DK1429770T3 (da) | Nye formuleringer og anvendelse deraf | |
PT1392670E (pt) | Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina |